Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

NCT04443348

Conditions
Biopsy-proven, Positive Lymph Node(s), Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)

NCT05460273

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +13 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Bengbu, China
View all 21 locations
View Trial Details
Active, Not Recruiting

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

NCT06449222

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +7 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

NCT05082259

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, United Kingdom
  • The Royal Marden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Breast Unit Sutton, United Kingdom
View Trial Details
Active, Not Recruiting

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

NCT02750358

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Kings County Hopsital Center Brooklyn, New York, United States
View Trial Details
Active, Not Recruiting

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

NCT04837209

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions